All In Biotech

Free tool

FAERS Monitor: Onyda Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217645 or its brand name (Onyda Xr, Clonidine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,745

Serious

3,867

67% of reports

Hospitalization

1,612

Death reported

915

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypertension762
  • headache712
  • off label use695
  • pain639
  • fatigue635
  • hypersensitivity549
  • drug ineffective529
  • nausea477
  • infusion related reaction442
  • hepatic enzyme increased437
  • joint swelling425
  • rash415
  • dyspnoea386
  • prescribed overdose374
  • diarrhoea370

Reports by year received

View as table
YearReports
20041
20055
20066
200710
200822
20098
201065
2011111
2012102
201367
201472
2015110
2016117
2017244
2018236
2019221
2020261
2021329
2022617
2023649
2024897
2025941
2026653

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,414 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prescribed overdoseSignal37472.165.325,681
infusion related reactionSignal44224.622.59,935
hepatic enzyme increasedSignal43723.621.69,410
hypertensionSignal76213.212.48,648
joint swellingSignal42512.911.84,677
hypersensitivitySignal54910.910.04,932
headacheSignal7124.23.91,757
painSignal6393.83.51,361
rashSignal4153.53.2749
fatigueSignal6353.02.8869
off label useSignal6952.92.7905
dyspnoeaSignal3862.52.3354
nauseaSignal4772.22.0326
diarrhoeaSignal3702.11.9218
drug ineffective5291.51.484

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.